Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-12

FDA Approved: APREPITANT — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved the original application for a generic aprepitant (APREPITANT) from BluePoint Laboratories, confirming a generic version of the antiemetic for its …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aprepitant (aprepitant)

Snippet

ORIG AP for APREPITANT (APREPITANT)